Health● Elevated42m ago · Nov 10, 2026, 12:01 AM
FDA warns of rare vision-loss side effect from GLP-1 drugs
GlobeAlert Desk · curated from CBS News · global
The Food and Drug Administration is adding a new warning about possible rare cases of vision loss reported with GLP-1 drugs like Ozempic, Wegovy and other brands.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
2 Elevated
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Health
Not flagged as developing.
More in Health
Health44m agoVeterans Day campaign aims to erase $35M in medical debt for nation heroesmyfox28columbus.com · United StatesHealth3h agoFDA warns of rare ‘eye stroke’ risk from GLP-1 drugsThe HillHealth3h agoSanta Barbara police investigate after 25 half marathon runners seek medical careThe Independent WorldHealth4h agoEli Lilly, Novo weight-loss drugs to get rare vision loss warningSeeking Alpha Tech